Platelet GPIIb/IIIa Receptor Antagonists in Human Ischemic Brain Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|6|1|29-36

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.6, Iss.1, 2008-01, pp. : 29-36

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Elevating local concentrations of GPIIb-IIIa antagonists counteracts platelet thrombus stability

By Speich Henry  

Journal of Thrombosis and Thrombolysis, Vol. 36, Iss. 1, 2013-07 ,pp. : 31-41

Springer Publishing Company

Access to resources Recommend Favorite

Oral Antiplatelet Efficacy of the Platelet GPIIb/IIIa Antagonist, DMP754 in Non-Human Primates - Receptor binding affinity & specificity

By Mousa S.A.   Bozarth J.   Youssef A.   Levine B.  

Thrombosis Research, Vol. 89, Iss. 5, 1998-03 ,pp. : 217-225

Elsevier

Access to resources Recommend Favorite

Progress in the Field of GPIIb/IIIa Antagonists

By  

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 2, Iss. 2, 2004-04 ,pp. : 157-167

Bentham Science Publishers

Access to resources Recommend Favorite

Comparison of the Effect of Different Platelet GPIIb/IIIa Antagonists on the Dynamics of Platelet/Fibrin-Mediated Clot Strength Induced Using Thromboelastography

By Mousa S.A.   Forsythe M.S.  

Thrombosis Research, Vol. 104, Iss. 1, 2001-10 ,pp. : 49-56

Elsevier

Access to resources Recommend Favorite

The Use of the Point of Care Helena ICHOR/Plateletworks® and the Accumetrics Ultegra® RPFA for Assessment of Platelet Function with GPIIb-IIIa Antagonists

By White Melanie   Krishnan Rajini   Kueter Teddi   Jacoski Mary   Jennings Lisa  

Journal of Thrombosis and Thrombolysis, Vol. 18, Iss. 3, 2004-12 ,pp. : 163-169

Springer Publishing Company

Access to resources Recommend Favorite